Skip to main content

12-05-2016 | Diabetes | News | Article

News in brief

‘Profound’ metabolic effects from modest weight loss in obese

medwireNews: A randomised trial published in Cell Metabolism demonstrates the “profound therapeutic effects” achievable by obese people who lose just 5% of their bodyweight.

The 19 obese, insulin-resistant participants who were randomly assigned to lose this much weight achieved multiple metabolic improvements, including lower plasma levels of glucose and insulin than the 14 assigned to maintain a stable weight. Although weight loss did not affect results of the oral glucose tolerance test, more specific tests revealed significantly improved insulin sensitivity in adipose, liver and skeletal muscle tissue.

The modest weight loss also improved insulin clearance and overall β-cell function, which Samuel Klein (Washington University School of Medicine, St Louis, Missouri, USA) and co-researchers note “have important clinical implications in preventing and treating type 2 diabetes”.

Progressive weight loss enhanced these metabolic benefits, they add.

By Eleanor McDermid

medwireNews is an independent medical news service provided by Springer Healthcare Limited. © Springer Healthcare Ltd; 2016

Related topics

See the research in context now

with trial summaries, expert opinion and congress coverage